Immunobiology Program

Program Leaders: Warren Pear, MD, PhD and E. John Wherry, PhD

The Immunobiology Program aims to:

  • Understand the fundamental aspects of immune biology, including activation, differentiation, inactivation, and transformation as these relate to cancer
  • Forge a comprehensive understanding of tumor immune surveillance using state-of-the-art in vitro, animal model, and human experimental systems
  • Translate novel clinical strategies for immunotherapy of cancer by the design, implementation, and analysis of proof-of-concept human clinical trials

The members’ collective expertise serves as a rich resource for the pursuit of interdisciplinary approaches to fundamental questions about the immunobiology and immunotherapy of cancer. Members include national leaders in basic immunology, tumor immunobiology and translational immunotherapy.

Immunobiology Program Membership